Clinical Integrated Systems Inc is categorized under Business Services (Unclassified) in Beaumont, TX and active since 2009.
Clinical Integrated Systems Inc was established in 2009, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Business Services (Unclassified) business, which does work in the B2B market, and is classified as a Business Services (Unclassified), under code number 561499 by the NAICS.
If you are seeking more information, feel free to contact Thomas Scott Pyle at the company’s single location by writing to 2120 Hazel St, Beaumont, Texas TX 77701 or by phoning (520) 784-3846. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical Integrated Systems Inc |
| Contact Person: | Thomas Scott Pyle |
| Address: | 2120 Hazel St, Beaumont, Texas 77701 |
| Phone Number: | (520) 784-3846 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Services (Unclassified) |
| SIC Code: | 7389 |
| NAICS Code: | 561499 |
| Share This Business: |
Clinical Integrated Systems Inc was started in 2009 to provide professional Business Services (Unclassified) under the SIC code 7389 and NAICS code 561499. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Thomas Scott Pyle for inquiries that concern Clinical Integrated Systems Inc by calling the company number (520) 784-3846, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Integrated Systems Inc can be found at the coordinates as well as the street address 2120 Hazel St in Beaumont, Texas 77701.
For its online presence, you may visit Clinical Integrated Systems Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.